| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Case Report |



From the * Division of Urology, Department of
Surgery, the
Department of Pathology, and the
Division of Hematology/Oncology, Department of
Internal Medicine, Tri-Service General Hospital, National Defense Medical
Center, Taipei, Taiwan, Republic of China.
| Correspondence to: Sun-Yran Chang, Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325, Sec 2, Cheng-Gung Rd, Nei-Hu, Taipei, Taiwan 114, Republic of China (e-mail: vins1023{at}ndmctsgh.edu.tw). |
| Received for publication April 12, 2006; accepted for publication June 1, 2006. |
Preoperative serum beta human chorionic gonadotropin (ß-hCG) concentration was 43.88 ng/mL (immunoradiometric assay, CIS bio), whereas the postoperative ß-hCG level decreased to normal (less than 0.15 ng/mL). Immunohistochemistry for ß-hCG (DAKO, 1:200) revealed focal staining (Figure 1C) in the resected tumor. Two courses of systemic chemotherapy with regimen of BEP (bleomycin 30 mg day 2, 9, and 16; etoposide 100 mg/M2 day 1 through day 5; cisplatin 20 mg/M2 day 1 through day 5) were given as adjuvant therapy. Postoperatively, the patient has been free of recurrence or disease progression for 7 months.
Most reports advocate radical inguinal orchiectomy with wide excision of the surrounding soft tissue as the standard treatment. Most distant metastases of spermatic cord leiomyosarcomas are either hematogenous to the lungs or liver, or pass via the lymphatic system to para-aortic lymph nodes. It appears that hematogenous metastasis is more frequent than lymphatic spread. Therefore, retroperitoneal lymph node dissection is not regularly recommended for patients with a spermatic cord leiomyosarcoma. Compared with surgery, the definite roles and therapeutic effects of adjuvant therapy, including chemotherapy and radiation therapy, are unknown. However, most physicians recommend radical surgery followed by radiation therapy or chemotherapy to achieve complete tumor regression. For this patient, we chose systemic chemotherapy rather than radiation therapy to abrogate any possibly hematogenous micrometastases after confirmation of a negative surgical margin. Cisplatin-based chemotherapy was used to treat the leiomyosarcoma, as there may also have been a syncytiotrophoblastic germ cell tumor with leiomyosarcoma differentiation.
Small intestine leiomyosarcomas that secrete ß-hCG have been reported
(Meredith et al, 1986). The
female patient presented with hyperemesis gravidarum, a paraneoplastic
syndrome caused by elevated level of serum ß-hCG. HCG is a heterodimeric
glycoprotein with a half-life of about 2436 hours, assembled from 2
nonconvalently linked
and ß subunits which are encoded by 2
different genes. The
subunit of hCG is common to LH, FSH, and TSH. The
ß subunit of hCG confers hormonal specificity and serves as a tumor
marker in the diagnosis and management of germ-cell tumors in men and of
choriocarcinomas in women. Nongonadal cells producing ß-hCG is associated
with tumors of poor prognosis such as cancers of the lungs, pancreas, and
liver. It may be secreted following metaplasia of the carcinomatous tissues
into a tissue similar to poorly differentiated trophoblast
cells.
|
Spermatic cord leiomyosarcomas with ß-hCG secretion demonstrated by immunohistochemistry stain have been reported in the German literature (Seidl et al, 1998). In our patient, rapid normalization of ß-hCG after tumor resection and positive immunohistochemistry stains of ß-hCG in the resected tumor provide strong evidences of paraneoplastic secretion of ß-hCG. To our knowledge, this has not been reported in the English medical literature. Because ß-hCG could be a paraneoplastic manifestation in spermatic cord leiomyosarcomas, we recommend serum ß-hCG as a biological marker to monitor and predict early recurrence in selective cases.
Acknowledgments
This study was supported in parts by the C. Y. Foundation for Advancement of Education, Sciences and Medicine.
Footnotes
DOI: 10.2164/jandrol.106.000224
References
Meredith RF, Wagman LD, Piper JA, Mills AS, Neifeld JP. Beta-chain human chorionic gonadotropin-producing leiomyosarcoma of the small intestine. Cancer. 1986;58: 131 135.[CrossRef][Medline]
Seidl C, Lippert C, Grouls V, Jellinghaus W. Leiomyosarcoma of the spermatic cord with paraneoplastic beta-hCG production [in German]. Pathologe. 1998; 19: 146 150.[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |